These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15523405)

  • 21. Diagnosis and management of medullary thyroid carcinoma.
    Massoll N; Mazzaferri EL
    Clin Lab Med; 2004 Mar; 24(1):49-83. PubMed ID: 15157557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of medullary thyroid carcinoma.
    Jiménez C; Hu MI; Gagel RF
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.
    van Veelen W; van Gasteren CJ; Acton DS; Franklin DS; Berger R; Lips CJ; Höppener JW
    Cancer Res; 2008 Mar; 68(5):1329-37. PubMed ID: 18316595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
    Menon MM; Simha MR
    Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.
    Dvorakova S; Vaclavikova E; Ryska A; Cap J; Vlcek P; Duskova J; Kodetova D; Holub V; Novak Z; Bendlova B
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations.
    Machens A; Holzhausen HJ; Thanh PN; Dralle H
    Surgery; 2003 Sep; 134(3):425-31. PubMed ID: 14555929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients.
    Fernández RM; Navarro E; Antiñolo G; Ruiz-Ferrer M; Borrego S
    Int J Mol Med; 2006 Apr; 17(4):575-81. PubMed ID: 16525712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers.
    Ukkat J; Lorenz K; Hinze R; Thomusch O; Dralle H
    World J Surg; 2001 Jun; 25(6):713-7. PubMed ID: 11376404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asymptomatic bilateral adrenal pheochromocytoma in a patient with a germline V804M mutation in the RET proto-oncogene.
    Recasens M; Oriola J; Fernández-Real JM; Roig J; Rodríguez-Hermosa JI; Font JA; Galofre P; López-Bermejo A; Ricart W
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):29-33. PubMed ID: 17466010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medullary thyroid carcinoma and some of its particularities].
    Sidibé el H
    Sante; 2007; 17(1):51-5. PubMed ID: 17897902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma.
    Colombo-Benkmann M; Li Z; Riemann B; Hengst K; Herbst H; Keuser R; Gross U; Rondot S; Raue F; Senninger N; Pützer BM; Frank-Raue K
    Eur J Endocrinol; 2008 Jun; 158(6):811-6. PubMed ID: 18322301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Case of medullary thyroid carcinoma with de novo V804M RET germline mutation.
    Choi YS; Kwon HJ; Kim BK; Kwon SK; Park YH; Kim JH; Jung SB; Lee CH; Lee SK; Uchino S
    J Korean Med Sci; 2013 Jan; 28(1):156-9. PubMed ID: 23341727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?
    Verga U; Ferrero S; Vicentini L; Brambilla T; Cirello V; Muzza M; Beck-Peccoz P; Fugazzola L
    Endocr Relat Cancer; 2007 Jun; 14(2):393-403. PubMed ID: 17639053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia.
    Lima J; Teixeira-Gomes J; Soares P; Máximo V; Honavar M; Williams D; Sobrinho-Simões M
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4932-7. PubMed ID: 14557476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer.
    Sponziello M; Benvenuti S; Gentile A; Pecce V; Rosignolo F; Virzì AR; Milan M; Comoglio PM; Londin E; Fortina P; Barnabei A; Appetecchia M; Marandino F; Russo D; Filetti S; Durante C; Verrienti A
    Hum Mutat; 2018 Mar; 39(3):371-377. PubMed ID: 29219214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medullary thyroid cancer: RET testing of an archival material.
    Godballe C; Jørgensen G; Gerdes AM; Krogdahl AS; Tybjaerg-Hansen A; Nielsen FC
    Eur Arch Otorhinolaryngol; 2010 Apr; 267(4):613-7. PubMed ID: 19823860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medullary thyroid carcinoma: role of genetic testing and calcitonin measurement.
    Lips CJ; Höppener JW; Thijssen JH
    Ann Clin Biochem; 2001 May; 38(Pt 3):168-79. PubMed ID: 11392493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.